methotrexate rheum oral
Selected indexed studies
- Treatment Guidelines in Rheumatoid Arthritis. (Rheum Dis Clin North Am, 2022) [PMID:35953230]
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. (Ann Rheum Dis, 2024) [PMID:38499325]
- EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. (Ann Rheum Dis, 2020) [PMID:31672775]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial. (2023) pubmed
- Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial. (2021) pubmed
- EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. (2020) pubmed
- Mycophenolate mofetil plus methotrexate versus cyclophosphamide with sequential azathioprine for treatment of Takayasu arteritis. (2025) pubmed
- Leflunomide. (2004) pubmed
- Treatment Guidelines in Rheumatoid Arthritis. (2022) pubmed
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. (2024) pubmed
- Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm. (2025) pubmed
- EULAR recommendations for calcium pyrophosphate deposition. Part II: management. (2011) pubmed
- Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendations. (2025) pubmed